These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34805874)

  • 1. Feasibility of CT-CT fusion imaging for evaluation of the cryoablation margins in visible hepatocellular carcinoma on unenhanced CT images: Initial experience.
    Chen C; Wang Y; Li G; Xu L; Wang Y; Huang H; Wang B; Li W; He X
    J Interv Med; 2019 May; 2(2):60-64. PubMed ID: 34805874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma.
    Tomonari A; Tsuji K; Yamazaki H; Aoki H; Kang JH; Kodama Y; Sakurai Y; Maguchi H
    Hepatol Res; 2013 Jul; 43(7):728-34. PubMed ID: 23198863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the cryoablation margin using MRI-CT fusion imaging in hepatic malignancies.
    Chen C; Xu LC; Wang Y; Wang YH; Li GD; Huang HZ; Wang B; Li WT; He XH
    Clin Radiol; 2019 Aug; 74(8):652.e21-652.e28. PubMed ID: 31076083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
    Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
    Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Ohama H; Matsumoto Y; Nakahara M; Zushi S; Kurokawa M; Isotani K; Takamura M; Fujita N; Murakami T
    Hepatol Res; 2013 Sep; 43(9):950-8. PubMed ID: 23356912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration.
    Minami Y; Minami T; Ueshima K; Yagyu Y; Tsurusaki M; Okada T; Hori M; Kudo M; Murakami T
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience.
    Orlacchio A; Bazzocchi G; Pastorelli D; Bolacchi F; Angelico M; Almerighi C; Masala S; Simonetti G
    Cardiovasc Intervent Radiol; 2008; 31(3):587-94. PubMed ID: 18236104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
    Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Iwamoto T; Okabe J; Takamura M; Fujita N; Hori M; Takehara T; Kudo M; Murakami T
    Liver Cancer; 2016 Oct; 5(4):269-279. PubMed ID: 27781199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.
    Takeyama N; Mizobuchi N; Sakaki M; Shimozuma Y; Munechika J; Kajiwara A; Uchikoshi M; Uozumi S; Ohgiya Y; Gokan T
    Abdom Radiol (NY); 2019 Mar; 44(3):923-935. PubMed ID: 30327828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
    Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
    BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
    Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.
    Kim HC; Kim AY; Han JK; Chung JW; Lee JY; Park JH; Choi BI
    Radiology; 2002 Dec; 225(3):773-80. PubMed ID: 12461260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
    Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
    Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety margins of hepatocellular carcinoma demonstrated by 3-dimensional fused images of computed tomographic hepatic arteriography/unenhanced computed tomography: prognostic significance in patients who underwent transcatheter arterial chemoembolization.
    Tajima T; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Kakihara D; Honda H
    J Comput Assist Tomogr; 2010; 34(5):712-9. PubMed ID: 20861774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
    Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
    Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report.
    Ye J; Huang G; Zhang X; Xu M; Zhou X; Lin M; Xie X; Xie X
    Int J Hyperthermia; 2019; 36(1):55-64. PubMed ID: 30444428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.